We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.42B
AUM Growth
+$598M
Cap. Flow
+$113M
Cap. Flow %
2.08%
Top 10 Hldgs %
21.05%
Holding
659
New
99
Increased
247
Reduced
154
Closed
55

Top Buys

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$39.8M
2
TRIP icon
TripAdvisor
TRIP
+$35.2M
3
JPM icon
JPMorgan Chase
JPM
+$31.3M
4
LKQ icon
LKQ Corp
LKQ
+$30.8M
5
MKTX icon
MarketAxess Holdings
MKTX
+$28.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.36%
2 Financials 17.1%
3 Industrials 14.55%
4 Technology 11.07%
5 Healthcare 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUS icon
151
Nu Skin
NUS
$247M
$2.4M 0.04%
+17,403
New +$2.05M
MO icon
152
Altria Group
MO
$122B
$2.4M 0.04%
62,529
-438
-0.7% -$16.2K
BIIB icon
153
Biogen
BIIB
$29.9B
$2.3M 0.04%
8,220
-19,045
-70% -$4.93M
EMC
154
DELISTED
EMC CORPORATION
EMC
$2.12M 0.04%
84,360
+1,618
+2% +$39.2K
PEP icon
155
PepsiCo
PEP
$186B
$2.11M 0.04%
25,437
+4,342
+21% +$361K
CHRD icon
156
Chord Energy
CHRD
$7.79B
$2.09M 0.04%
44,520
+270
+0.6% +$13.4K
PFE icon
157
Pfizer
PFE
$140B
$2.04M 0.04%
70,194
-2,790
-4% -$81.2K
WMT icon
158
Walmart Inc
WMT
$871B
$2.02M 0.04%
76,854
+420
+0.5% +$10.8K
MOS icon
159
The Mosaic Company
MOS
$7.09B
$1.96M 0.04%
41,505
+188
+0.5% +$8.72K
NVRI icon
160
Enviri
NVRI
$621M
$1.92M 0.04%
68,302
ORCL icon
161
Oracle
ORCL
$331B
$1.89M 0.03%
49,482
+4,737
+11% +$163K
VZ icon
162
Verizon
VZ
$194B
$1.85M 0.03%
37,667
+2,540
+7% +$125K
TEVA icon
163
Teva Pharmaceuticals
TEVA
$35.9B
$1.79M 0.03%
44,682
+14,250
+47% +$561K
ESRX
164
DELISTED
Express Scripts Holding Company
ESRX
$1.78M 0.03%
25,412
+356
+1% +$23.2K
NVS icon
165
Novartis
NVS
$295B
$1.78M 0.03%
24,679
+474
+2% +$32.9K
BDX icon
166
Becton Dickinson
BDX
$43.1B
$1.77M 0.03%
16,471
+247
+2% +$25.6K
SLXP
167
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$1.75M 0.03%
+19,462
New +$1.55M
PHO icon
168
Invesco Water Resources ETF
PHO
$1.97B
$1.75M 0.03%
66,610
-1,335
-2% -$33.1K
SPY icon
169
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.75M 0.03%
9,461
-307
-3% -$54.3K
SSW.PRD
170
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
$1.74M 0.03%
+69,800
New +$1.76M
EOG icon
171
EOG Resources
EOG
$78B
$1.72M 0.03%
20,438
-8,030
-28% -$688K
JEF icon
172
Jefferies Financial Group
JEF
$12.9B
$1.7M 0.03%
67,040
-5,475
-8% -$139K
BKNG icon
173
Booking.com
BKNG
$138B
$1.69M 0.03%
36,275
+9,500
+35% +$423K
KFN.PR.CL
174
DELISTED
KKR Financial Holdings LLC
KFN.PR.CL
$1.68M 0.03%
69,520
+5,600
+9% +$134K
KO icon
175
Coca-Cola
KO
$354B
$1.66M 0.03%
40,244
-1,120
-3% -$44.2K

Similar funds

Geneva Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Geneva Advisors held 659 positions worth $5.42B, up 12% from $4.82B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q4 2013 filing shows 99 new, 247 increased, 154 reduced and 55 closed positions. Its largest new stake was LORILLARD INC COM STK: 798,445 shares worth $40.5M. The largest sale was RoadRunner Transportation Systems, Inc., an estimated $34.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2013 buy was LORILLARD INC COM STK: 798,445 shares worth $40.5M.
  • Geneva Advisors added most to JPMorgan Chase in Q4 2013, an estimated $31.3M increase.
  • Geneva Advisors's biggest Q4 2013 reduction was Chevron, cutting an estimated $33.8M.
  • Geneva Advisors fully exited RoadRunner Transportation Systems, Inc. in Q4 2013, selling an estimated $34.7M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.42B portfolio in Q4 2013.
  • Geneva Advisors opened 99 new positions and closed 55 in Q4 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $5.42B.

Based on Geneva Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.